Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHFR | P00374 | 13/20 | 1.00 |
| ▸ | FOLR1 | P15328 | 2/20 | 0.82 |
| ▸ | SLC19A1 | P41440 | 2/20 | 0.82 |
| ▸ | SLC46A1 | Q96NT5 | 2/20 | 0.82 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.70 |
| ▸ | TLR4 | O00206 | 1/20 | 0.70 |
| ▸ | MEN1 | O00255 | 1/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.70 |
| ▸ | LMNA | P02545 | 1/20 | 0.70 |
| ▸ | TP53 | P04637 | 1/20 | 0.70 |
| ▸ | TYMS | P04818 | 1/20 | 0.70 |
| ▸ | GLA | P06280 | 1/20 | 0.70 |
| ▸ | POLB | P06746 | 1/20 | 0.70 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.70 |
| ▸ | MAPT | P10636 | 1/20 | 0.70 |
| ▸ | FOLR2 | P14207 | 1/20 | 0.70 |
| ▸ | HPGD | P15428 | 1/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.70 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.70 |
| ▸ | GART | P22102 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Edatrexate SCHEMBL20769788 | 1.00 | DHFR (1.00) | DHFRFOLR1SLC19A1SLC46A1KDM4E | |
| Edatrexate SCHEMBL29352085 | 1.00 | DHFR (1.00) | DHFRFOLR1SLC19A1SLC46A1KDM4E | |
| Edatrexate SCHEMBL1650127 | 1.00 | DHFR (1.00) | DHFRFOLR1SLC19A1SLC46A1KDM4E | |
| Pralatrexate SCHEMBL21633 | 0.90 | DHFR (1.00) | DHFRFOLR1SLC19A1SLC46A1KDM4E | |
| Pralatrexate SCHEMBL29904921 | 0.90 | DHFR (1.00) | DHFRFOLR1SLC19A1SLC46A1KDM4E | |
| Pralatrexate SCHEMBL29904925 | 0.90 | DHFR (1.00) | DHFRFOLR1SLC19A1SLC46A1KDM4E | |
| Pralatrexate SCHEMBL15075302 | 0.90 | DHFR (1.00) | DHFRFOLR1SLC19A1SLC46A1KDM4E | |
| Pralatrexate SCHEMBL1889869 | 0.90 | DHFR (1.00) | DHFRFOLR1SLC19A1SLC46A1KDM4E | |
| Pralatrexate SCHEMBL2336143 | 0.90 | DHFR (1.00) | DHFRFOLR1SLC19A1SLC46A1KDM4E | |
| Pralatrexate SCHEMBL29355142 | 0.90 | DHFR (1.00) | DHFRFOLR1SLC19A1SLC46A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 32395 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4748859-A2 | CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF | The Regents of the University of California (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260137678-A1 | METHODS FOR TREATING OR PREVENTING NEUROENDOCRINE TUMOR FORMATION USING XPO1 INHIBITORS | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2026-05-21 | — | — | US | claimed |
| EP-4743490-A1 | HUMANIZED ANTI-CD7 ANTIBODY | Christian-Albrechts-Universität zu Kiel (DE) | 2026-05-20 | — | — | EP | claimed |
| WO-2026099502-A1 | NOVEL DRUG CONJUGATES FOR TESTING CELLULAR DRUG UPTAKE | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2026-05-15 | — | — | WO | claimed |
| US-20260130855-A1 | GAMMA POLYGLUTAMATED ANTIFOLATES AND USES THEREOF | L E A F HOLDINGS GROUP LLC (US) | 2026-05-14 | — | — | US | claimed |
| US-20260116861-A1 | ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS | THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION (US) | 2026-04-30 | — | — | US | claimed |
| US-20260115305-A1 | LINKERS, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) | 2026-04-30 | — | — | US | claimed |
| EP-4729063-A2 | TREATMENT OF CANCER USING COENZYME Q10 COMBINATION THERAPIES | BPGbio, Inc. (US) | 2026-04-22 | — | — | EP | claimed |
| US-20260077056-A1 | LINKER-PAYLOAD COMPOUND, CONJUGATES AND APPLICATIONS THEREOF | GENEQUANTUM HEALTHCARE SUZHOU CO LTD (CN) | 2026-03-19 | — | — | US | claimed |
| EP-4698185-A1 | METHODS AND SYSTEMS FOR IMPROVING ANTI-CANCER THERAPIES | Osasuna Therapeutics SA (CH) | 2026-02-25 | — | — | EP | claimed |
| EP-0912535-A1 | CONJUGATES OF CIS-DOCOSAHEXAENOIC ACID AND PACLITAXEL | Neuromedica, Inc. (US) | 1999-05-06 | — | — | EP | claimed |
| WO-1999001118-A2 | ANTIOXIDANT ENHANCEMENT OF THERAPY FOR HYPERPROLIFERATIVE CONDITIONS | ATHEROGENICS, INC. (US) | 1999-01-14 | — | — | WO | claimed |
| EP-0877615-A1 | COMBINATION THERAPY METHOD FOR TREATING CANCER USING EDATREXATE AND A TAXANE DERIVATIVE, E.G. PACLITAXEL | Sloan-Kettering Institute For Cancer Research (US) | 1998-11-18 | — | — | EP | claimed |
| WO-1998037898-A1 | SYNERGISTICALLY ACTING ANTI-FUNGAL AGENTS THAT ARE INHIBITORS OF FOLATE METABOLISM, ESPECIALLY METHOTREXATE AND SULFAMETHOXAZOLE | BARCLAY BARRY J (CA) | 1998-09-03 | — | — | WO | claimed |
| WO-1997044336-A9 | CONJUGATES OF CIS-DOCOSAHEXAENOIC ACID AND PACLITAXEL | — | 1998-04-16 | — | — | WO | claimed |
| WO-1997048391-A2 | METHODS AND COMPOSITIONS COMPRISING R-IBUPROFEN | ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE (US) | 1997-12-24 | — | — | WO | claimed |
| WO-1997044336-A1 | CONJUGATES OF CIS-DOCOSAHEXAENOIC ACID AND PACLITAXEL | NEUROMEDICA, INC. (US) | 1997-11-27 | — | — | WO | claimed |
| WO-1997044026-A1 | COMPOSITIONS COMPRISING CONJUGATES OF CIS-DOCOSAHEXAENOIC ACID AND TAXOTERE | NEUROMEDICA, INC. (US) | 1997-11-27 | — | — | WO | claimed |
| WO-1997027858-A1 | COMBINATION THERAPY METHOD FOR TREATING CANCER USING EDATREXATE AND A TAXANE DERIVATIVE, E.G. PACLITAXEL | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1997-08-07 | — | — | WO | claimed |
| WO-1993013102-A1 | DEAZAAMINOPTERINS | SOUTHERN RESEARCH INSTITUTE (US) | 1993-07-08 | — | — | WO | claimed |